Answers are grounded in this paper and cite their sources.
This review aims to summarize recent progress in brain organoid technology for research into neural regeneration, focusing on its theoretical foundations, technical development, translational challenges, and future directions. Brain organoids are three-dimensional biomimetic in vitro models that capture some key features of neural development and pathology. They provide platforms for investigating brain tissue organization and the molecular and cellular processes underlying neural regeneration. Their potential applications include studying disease mechanisms and brain injury, testing neurotoxicity, and screening drugs for neurological disorders. Organoids may also inform research on tissue repair and transplantation, although their clinical applications remain under investigation. This review examines current approaches to generating and improving brain organoids, as well as the technical, ethical, and regulatory issues that may affect their use and translation. Key limitations include incomplete maturation and vascularization, the absence of important immune components, and variation between models arising from limited standardization. Future research could explore guided culture and assembly, high-throughput screening, and bioprinting to improve model performance. Multi-omics approaches may also help characterize organoids and support efforts to strengthen standardization. In addition, combining organoid platforms with gene-editing techniques may offer further opportunities for studying disease mechanisms. This review identifies research priorities and discusses how more accurate models, rigorous quality control, and appropriate oversight may support the further development of brain organoids for neural regeneration research.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: